Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients
Introduction The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren’s syndrome (pSS). Methods Seventy-five pSS patients...
Saved in:
Published in | Clinical rheumatology Vol. 38; no. 5; pp. 1301 - 1307 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Springer London
01.05.2019
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0770-3198 1434-9949 1434-9949 |
DOI | 10.1007/s10067-019-04438-z |
Cover
Loading…
Abstract | Introduction
The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren’s syndrome (pSS).
Methods
Seventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with
U
Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at
p
< 0.05. The approval of the Bioethics Committee was obtained.
Results
Two subgroups I-RF(+) (61%) and II-RF(−) (39%) were established, with lower WBC (
p
= 0.012) and higher ESR (
p
= 0.016), gammaglobulin concentration (
p
= 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0;
p
< 0.003). RF correlated negatively with WBC (rho = − 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+.
Conclusions
RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity. |
---|---|
AbstractList | IntroductionThe rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren’s syndrome (pSS).MethodsSeventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained.ResultsTwo subgroups I-RF(+) (61%) and II-RF(−) (39%) were established, with lower WBC (p = 0.012) and higher ESR (p = 0.016), gammaglobulin concentration (p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = − 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+.ConclusionsRF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity. The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren's syndrome (pSS).INTRODUCTIONThe rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren's syndrome (pSS).Seventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained.METHODSSeventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained.Two subgroups I-RF(+) (61%) and II-RF(-) (39%) were established, with lower WBC (p = 0.012) and higher ESR (p = 0.016), gammaglobulin concentration (p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = - 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+.RESULTSTwo subgroups I-RF(+) (61%) and II-RF(-) (39%) were established, with lower WBC (p = 0.012) and higher ESR (p = 0.016), gammaglobulin concentration (p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = - 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+.RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity.CONCLUSIONSRF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity. The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren's syndrome (pSS). Seventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained. Two subgroups I-RF(+) (61%) and II-RF(-) (39%) were established, with lower WBC (p = 0.012) and higher ESR (p = 0.016), gammaglobulin concentration (p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = - 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+. RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity. Introduction The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the role of RF as an immunological and prognostic factor in the primary Sjögren’s syndrome (pSS). Methods Seventy-five pSS patients (mean age 50.03 ± 15.1), 65 (87%) females, and 10 (13%) males. WBC, CRP, RF, ESR, gammaglobulins, C4, C3 component of complement, cryoglobulins, ANA, anti-SS-A, and anti-SS-B antibodies were determined. The disease activity assessed with ESSDAI. Minor salivary gland biopsy (focus score and immunochemistry) was conducted. Results were analyzed with U Mann-Whitney (continuous variables) tests, correlations between quantitative variables assessed with the Spearman correlation coefficient with statistical significance set at p < 0.05. The approval of the Bioethics Committee was obtained. Results Two subgroups I-RF(+) (61%) and II-RF(−) (39%) were established, with lower WBC ( p = 0.012) and higher ESR ( p = 0.016), gammaglobulin concentration ( p = 0.007) in group I. Conjunctivitis sicca was more severe in group I. There was positive correlation between RF and lnANA (rho = 0.496), anti-SS-A, anti-SS-B antibodies (rho = 0.448; rho = 0.397 respectively). There was higher disease activity ESSDAI in group I than in group II (Me, 3.0 vs 2.0; p < 0.003). RF correlated negatively with WBC (rho = − 0.374). RF did not correlate with serum concentrations of BAFF, APRIL, CRP, and C3, C4 and with CD19+, CD3+, CD4+, CD 21+, and CD35+. Conclusions RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity. |
Author | Kwiatkowska, Brygida Maślińska, Maria Mańczak, Małgorzata |
Author_xml | – sequence: 1 givenname: Maria orcidid: 0000-0002-2211-0302 surname: Maślińska fullname: Maślińska, Maria email: maslinskam@gmail.com organization: National Institute of Geriatrics, Rheumatology and Rehabilitation, Early Arthritis Clinic – sequence: 2 givenname: Małgorzata surname: Mańczak fullname: Mańczak, Małgorzata organization: Department of Gerontology and Public Health, National Institute of Geriatrics, Rheumatology and Rehabilitation – sequence: 3 givenname: Brygida surname: Kwiatkowska fullname: Kwiatkowska, Brygida organization: National Institute of Geriatrics, Rheumatology and Rehabilitation, Early Arthritis Clinic |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30810912$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9rHCEYxqWkNLvbfoEeipBLL5P6b2b0GEKaFAIpbHPoSRxHN25mdKvOIfvp42ayFHLIRfHl97w8j88SnPjgDQBfMTrHCLU_UjmbtkJYVIgxyqv9B7DAjLJKCCZOwAK1LaooFvwULFPaIoQIF_gTOKWIYyQwWYC_98nYafAmJRgsjA9mGlUOrodW6RwiVAkqD904Tj4MYeO0Gsqgh7sYNj6k7DQcVXw0EToPf6_XcKeyMz6nz-CjVUMyX17vFbj_efXn8qa6vbv-dXlxW2mGRa4EVj3RurGUMNTVvLaWNZ2yHe9tz-raakS6WrCatKIkIVZ3TadVpyk_PBVdge_z3uLo32RSlqNL2gyD8iZMSRLMm4ZQwXFBz96g2zBFX9zNFCWkJoX69kpN3Wh6uYuuJHySx08rAJ8BHUNK0VipXS6pg89RuUFiJA_9yLkfWfqRL_3IfZGSN9Lj9ndFdBalAvuNif9tv6N6Bqyoow4 |
CitedBy_id | crossref_primary_10_1007_s10067_019_04540_2 crossref_primary_10_1016_j_trim_2021_101436 crossref_primary_10_20492_aeahtd_1035777 crossref_primary_10_1024_1661_8157_a003442 crossref_primary_10_1016_j_jns_2024_123215 crossref_primary_10_5114_reum_192613 crossref_primary_10_1515_cclm_2022_0244 crossref_primary_10_1111_cei_13508 crossref_primary_10_3390_jcm11010003 crossref_primary_10_1007_s10067_019_04869_8 crossref_primary_10_1111_1756_185X_14936 crossref_primary_10_1007_s00296_020_04782_3 crossref_primary_10_2147_JIR_S365326 crossref_primary_10_1016_j_ajo_2020_12_019 crossref_primary_10_1007_s10067_023_06818_y crossref_primary_10_1016_j_autrev_2020_102686 crossref_primary_10_1136_ard_2023_223901 |
Cites_doi | 10.1136/annrheumdis-2012-202293 10.1097/00005792-200207000-00004 10.1007/s002960050112 10.1007/s00296-009-0997-1 10.1016/j.bbrc.2009.09.012 10.1002/art.39518 10.1186/s12865-017-0234-8 10.1186/ar3348 10.1136/annrheumdis-2011-201117 10.1016/j.semarthrit.2012.11.007 10.1159/000066861 10.1186/ar4442 10.1136/bmj.e5244 10.1006/clim.2002.5210 10.1093/rheumatology/keu417 10.1016/j.jaut.2010.06.012 10.1002/acr.21591 10.1155/2013/726598 10.1136/bmj.e5841 10.1186/ar4152 10.1002/acr.23762 |
ContentType | Journal Article |
Copyright | The Author(s) 2019 Clinical Rheumatology is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2019 – notice: Clinical Rheumatology is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s10067-019-04438-z |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1434-9949 |
EndPage | 1307 |
ExternalDocumentID | 30810912 10_1007_s10067_019_04438_z |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Institute of Geriatrics, Rheumatology and Rehabilitation |
GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 36B 4.4 406 408 409 40D 40E 5GY 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CCPQU CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- N9A NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RNS ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX VC2 W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX ~KM -Y2 1SB 28- 2P1 2VQ 53G 5QI AANXM AAPKM AARHV AAYTO AAYXX ABBRH ABDBE ABFSG ABQSL ABULA ACBXY ACSTC ACUDM ADHKG AEBTG AEFIE AEKMD AEZWR AFDZB AFEXP AFHIU AFLOW AFOHR AGGDS AGQPQ AHPBZ AHWEU AIXLP AJBLW ATHPR AYFIA BBWZM CAG CITATION COF EN4 GRRUI H13 KOW N2Q NDZJH O9- PHGZM PHGZT R4E RIG RNI RZK S1Z S26 S28 SCLPG SDE T16 UZXMN VFIZW ZGI CGR CUY CVF ECM EIF NPM 3V. 7T5 7XB 8FK ABRTQ H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c419t-91ad2cc6f3240b585ff46bafb8dfd455fc02b59452791982fcb6bcabc381982a3 |
IEDL.DBID | U2A |
ISSN | 0770-3198 1434-9949 |
IngestDate | Fri Jul 11 05:41:09 EDT 2025 Fri Jul 25 07:05:48 EDT 2025 Thu Apr 03 06:56:33 EDT 2025 Tue Jul 01 04:05:09 EDT 2025 Thu Apr 24 22:55:44 EDT 2025 Fri Feb 21 02:38:52 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Prognostic factor Rheumatoid factor Sjögren’s syndrome |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c419t-91ad2cc6f3240b585ff46bafb8dfd455fc02b59452791982fcb6bcabc381982a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2211-0302 |
OpenAccessLink | https://link.springer.com/10.1007/s10067-019-04438-z |
PMID | 30810912 |
PQID | 2186632252 |
PQPubID | 326351 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2186623981 proquest_journals_2186632252 pubmed_primary_30810912 crossref_citationtrail_10_1007_s10067_019_04438_z crossref_primary_10_1007_s10067_019_04438_z springer_journals_10_1007_s10067_019_04438_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20190501 2019-5-00 2019-May |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 5 year: 2019 text: 20190501 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Germany – name: Heidelberg |
PublicationSubtitle | Journal of the International League of Associations for Rheumatology |
PublicationTitle | Clinical rheumatology |
PublicationTitleAbbrev | Clin Rheumatol |
PublicationTitleAlternate | Clin Rheumatol |
PublicationYear | 2019 |
Publisher | Springer London Springer Nature B.V |
Publisher_xml | – name: Springer London – name: Springer Nature B.V |
References | Cornec, Saraux, Pers, Jousse-Joulin, Marhadour, Roguedas-Contios, Genestet, Renaudineau, Devauchelle-Pensec (CR5) 2014; 16 Orge, Cefle, Yazici, Gürel-Polat, Hulagu (CR3) 2010; 30 Gottenberg, Cinquetti, Larroche (CR20) 2013; 72 Ingegnoli, Castelli, Gualtierotti (CR1) 2013; 35 Isaacs, Cohen, Emery, Tak, Wang, Lei, Williams, Lal, Read (CR23) 2013; 72 Ramos-Casals, Font, Garcia-Carrasco (CR14) 2002; 81 Nielsen, Bojeson, Schnohr, Nordestaarg (CR7) 2012; 345 Shiboski, Shiboski, Criswell (CR13) 2012; 64 Maneiro, Salgado, Carmona, Gomez-Reino (CR22) 2013; 43 Simard (CR8) 2012; 345 Nocturne, Virone, Ng, le Guern, Hachulla, Cornec, Daien, Vittecoq, Bienvenu, Marcelli, Wendling, Amoura, Dhote, Lavigne, Fior, Gottenberg, Seror, Mariette (CR16) 2016; 68 CR19 Youinou, Pers (CR11) 2011; 13 Jones, Shyu, Newkirk, Rigby (CR24) 2013; 15 Newkirk, Lepage, Niwa, Rubin (CR9) 1998; 44 Haberman, William, Euler, Shlomchik (CR2) 2003; 6 Mizuochi, Ito, Takai, Yamaguchi (CR6) 2009; 389 Flores-Chávez, Kostov, Solans (CR18) 2018; 36 Suppl 112 Sada, Isenberg, Ciurtin (CR21) 2015; 54 Watanabe, Gono, Nishina, Sugitani, Watanabe, Yabe, Terai (CR17) 2017; 18 Diaz-Lopez, Geli, Corominasetal (CR12) 2004; 31 Newkirk (CR4) 2002; 104 Witte, Hartung, Sachse (CR15) 2000; 19 Mavragani, Crow (CR10) 2010; 35 E Orge (4438_CR3) 2010; 30 M Ramos-Casals (4438_CR14) 2002; 81 MM Newkirk (4438_CR4) 2002; 104 MM Newkirk (4438_CR9) 1998; 44 T Witte (4438_CR15) 2000; 19 JD Isaacs (4438_CR23) 2013; 72 SC Shiboski (4438_CR13) 2012; 64 T Mizuochi (4438_CR6) 2009; 389 D Cornec (4438_CR5) 2014; 16 RJ Maneiro (4438_CR22) 2013; 43 G Nocturne (4438_CR16) 2016; 68 S Watanabe (4438_CR17) 2017; 18 JF Simard (4438_CR8) 2012; 345 JE Gottenberg (4438_CR20) 2013; 72 P Youinou (4438_CR11) 2011; 13 F Ingegnoli (4438_CR1) 2013; 35 CP Mavragani (4438_CR10) 2010; 35 AM Haberman (4438_CR2) 2003; 6 4438_CR19 SF Nielsen (4438_CR7) 2012; 345 C Diaz-Lopez (4438_CR12) 2004; 31 A Flores-Chávez (4438_CR18) 2018; 36 Suppl 112 PR Sada (4438_CR21) 2015; 54 JD Jones (4438_CR24) 2013; 15 |
References_xml | – volume: 72 start-page: 1026 year: 2013 end-page: 1031 ident: CR20 article-title: Efficacy of rituximab in systemic manifestations of primary Sjogren’s syndrome: results in 78 patients of the Autoimmune and Rituximab registry publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-202293 – volume: 81 start-page: 281 year: 2002 end-page: 292 ident: CR14 article-title: Primary Sjogren syndrome: hematologic patterns of disease expression publication-title: Medicine (Baltimore) doi: 10.1097/00005792-200207000-00004 – volume: 19 start-page: 107 year: 2000 end-page: 111 ident: CR15 article-title: Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group publication-title: Rheumatol Int doi: 10.1007/s002960050112 – ident: CR19 – volume: 30 start-page: 485 issue: 4 year: 2010 end-page: 488 ident: CR3 article-title: The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection publication-title: Rheumatol Int doi: 10.1007/s00296-009-0997-1 – volume: 389 start-page: 512 issue: 3 year: 2009 end-page: 515 ident: CR6 article-title: Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.09.012 – volume: 36 Suppl 112 start-page: 121 issue: 3 year: 2018 end-page: 129 ident: CR18 article-title: Severe, life-threatening phenotype of primary Sjögren’s syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry) publication-title: Clin Exp Rheumatol – volume: 68 start-page: 977 year: 2016 end-page: 985 ident: CR16 article-title: Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren’s syndrome publication-title: Arthritis Rheumatol doi: 10.1002/art.39518 – volume: 18 start-page: 53 year: 2017 ident: CR17 article-title: Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody- associated vasculitis publication-title: BMC Immunol doi: 10.1186/s12865-017-0234-8 – volume: 13 start-page: 227 year: 2011 ident: CR11 article-title: Disturbance of cytokine networks in Sjögren’s syndrome publication-title: Arthritis Res Ther doi: 10.1186/ar3348 – volume: 72 start-page: 329 issue: 3 year: 2013 end-page: 336 ident: CR23 article-title: Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2011-201117 – volume: 43 start-page: 9 issue: 1 year: 2013 end-page: 17 ident: CR22 article-title: Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: systematic review and meta-analysis publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2012.11.007 – volume: 31 start-page: 1352 issue: 7 year: 2004 end-page: 1355 ident: CR12 article-title: Are there clinical or serological differences between male and female patients with primary Sjögren’s syndrome? publication-title: J Rheumatol – volume: 6 start-page: 169 year: 2003 end-page: 195 ident: CR2 article-title: Rheumatoid factors in health and disease: structure, function, induction and regulation publication-title: Curr Dir Autoimmun doi: 10.1159/000066861 – volume: 16 start-page: R15 year: 2014 ident: CR5 article-title: Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in primary Sjogren’s syndrome publication-title: Arthritis Res Ther doi: 10.1186/ar4442 – volume: 44 start-page: 1129 year: 1998 end-page: 1138 ident: CR9 article-title: Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with Rheumatoid Arthritis (RA) publication-title: Cell Molec Biol – volume: 345 start-page: e5244 year: 2012 ident: CR7 article-title: Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study publication-title: BMJ doi: 10.1136/bmj.e5244 – volume: 104 start-page: 1 year: 2002 end-page: 13 ident: CR4 article-title: Rheumatoid factors: host resistance or autoimmunity? publication-title: Clin Immunol doi: 10.1006/clim.2002.5210 – volume: 54 start-page: 219 year: 2015 end-page: 230 ident: CR21 article-title: Biologic treatment in Sjögren’s syndrome publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keu417 – volume: 35 start-page: 225 year: 2010 end-page: 231 ident: CR10 article-title: Activation of the type I interferon pathway in primary Sjögren’s syndrome publication-title: J Autoimmun doi: 10.1016/j.jaut.2010.06.012 – volume: 64 start-page: 475 year: 2012 end-page: 487 ident: CR13 article-title: American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21591 – volume: 35 start-page: 727 issue: 6 year: 2013 end-page: 734 ident: CR1 article-title: Rheumatoid factor: clinicla applications publication-title: Dis Markers doi: 10.1155/2013/726598 – volume: 345 start-page: e5841 year: 2012 ident: CR8 article-title: Rheumatoid factor positivity in the general population. Is unlikely to be discovered incidentally publication-title: BMJ doi: 10.1136/bmj.e5841 – volume: 15 start-page: R20 issue: 1 year: 2013 ident: CR24 article-title: A rheumatoid factor paradox: inhibition of rituximab effector function publication-title: Arthritis Res Ther doi: 10.1186/ar4152 – volume: 13 start-page: 227 year: 2011 ident: 4438_CR11 publication-title: Arthritis Res Ther doi: 10.1186/ar3348 – volume: 43 start-page: 9 issue: 1 year: 2013 ident: 4438_CR22 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2012.11.007 – volume: 35 start-page: 727 issue: 6 year: 2013 ident: 4438_CR1 publication-title: Dis Markers doi: 10.1155/2013/726598 – volume: 15 start-page: R20 issue: 1 year: 2013 ident: 4438_CR24 publication-title: Arthritis Res Ther doi: 10.1186/ar4152 – volume: 30 start-page: 485 issue: 4 year: 2010 ident: 4438_CR3 publication-title: Rheumatol Int doi: 10.1007/s00296-009-0997-1 – volume: 72 start-page: 1026 year: 2013 ident: 4438_CR20 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-202293 – volume: 345 start-page: e5244 year: 2012 ident: 4438_CR7 publication-title: BMJ doi: 10.1136/bmj.e5244 – volume: 31 start-page: 1352 issue: 7 year: 2004 ident: 4438_CR12 publication-title: J Rheumatol – volume: 16 start-page: R15 year: 2014 ident: 4438_CR5 publication-title: Arthritis Res Ther doi: 10.1186/ar4442 – volume: 72 start-page: 329 issue: 3 year: 2013 ident: 4438_CR23 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2011-201117 – volume: 104 start-page: 1 year: 2002 ident: 4438_CR4 publication-title: Clin Immunol doi: 10.1006/clim.2002.5210 – volume: 35 start-page: 225 year: 2010 ident: 4438_CR10 publication-title: J Autoimmun doi: 10.1016/j.jaut.2010.06.012 – volume: 64 start-page: 475 year: 2012 ident: 4438_CR13 publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21591 – volume: 389 start-page: 512 issue: 3 year: 2009 ident: 4438_CR6 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.09.012 – volume: 81 start-page: 281 year: 2002 ident: 4438_CR14 publication-title: Medicine (Baltimore) doi: 10.1097/00005792-200207000-00004 – volume: 36 Suppl 112 start-page: 121 issue: 3 year: 2018 ident: 4438_CR18 publication-title: Clin Exp Rheumatol – volume: 18 start-page: 53 year: 2017 ident: 4438_CR17 publication-title: BMC Immunol doi: 10.1186/s12865-017-0234-8 – volume: 54 start-page: 219 year: 2015 ident: 4438_CR21 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keu417 – volume: 345 start-page: e5841 year: 2012 ident: 4438_CR8 publication-title: BMJ doi: 10.1136/bmj.e5841 – volume: 44 start-page: 1129 year: 1998 ident: 4438_CR9 publication-title: Cell Molec Biol – volume: 19 start-page: 107 year: 2000 ident: 4438_CR15 publication-title: Rheumatol Int doi: 10.1007/s002960050112 – volume: 6 start-page: 169 year: 2003 ident: 4438_CR2 publication-title: Curr Dir Autoimmun doi: 10.1159/000066861 – volume: 68 start-page: 977 year: 2016 ident: 4438_CR16 publication-title: Arthritis Rheumatol doi: 10.1002/art.39518 – ident: 4438_CR19 doi: 10.1002/acr.23762 |
SSID | ssj0002891 |
Score | 2.3146293 |
Snippet | Introduction
The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study... The rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study assesses the... IntroductionThe rheumatoid factor (RF) is present in numerous autoimmune disorders, although its role in many of them remains a subject of research. The study... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1301 |
SubjectTerms | Adult Aged Antibodies, Antinuclear - blood APRIL protein Autoantibodies Autoimmune Collection 2018 Autoimmune diseases Biomarkers - blood Biopsy BLyS protein CD19 antigen CD3 antigen CD4 antigen Complement component C3 Complement component C4 Conjunctivitis Cryoglobulins Female Fluorescent Antibody Technique, Indirect Humans Immunology Lymphocytes B Male Medicine Medicine & Public Health Middle Aged Original Article Predictive Value of Tests Rheumatoid factor Rheumatoid Factor - blood Rheumatology Salivary gland Salivary Glands, Minor - pathology Sjogren's syndrome Sjogren's Syndrome - diagnosis Sjogren's Syndrome - pathology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA86QXwRv51OieCbFrcuSdsnEXEMQRHmYD6VfOJgtnPdXvbXe9elGyLutU3acF-5y11-R8i1UUlbOCcCrR0PmNYCVCqGwLUZWSONiKwrC2RfRbfPngd84A_cCl9WWdnE0lCbXOMZ-R32ThIofeH9-DvArlGYXfUtNDbJFkKXYUlXNFgGXJhEKzvmRRHamiT2l2b81Tmw0xBIY2qAgdLPf29Mf7zNP5nScgPq7JFd7znShwWr98mGzQ7I9ovPjR-Sj35h3WyEpovmjk4-7Qy80Xxo6KKnDpUFlRkd4oWQyuLBA0OxRCvLEa-ZfmGxzoQOM_rW61GPuVockX7n6f2xG_jGCYFmrWQK1JYmBLI7RNtTEBA4x4SSTsXGGca5081Q8YTxMEqALKHTSigtlcbwLQ5l-5jUsjyzp4Ryw4VtS2eEUkzHLDZJaIyMW44rCE1knbQqqqXao4pjc4tRusJDRkqnQOm0pHQ6r5Ob5ZzxAlNj7ehGxYzU61eRrqShTq6Wr0EzMN0hM5vP_BiEN2zVycmCicvftcETAk8JZt9WXF19_P-1nK1fyznZCUuJwnrIBqlNJzN7AT7LVF2WgvkDVenn9A priority: 102 providerName: ProQuest |
Title | Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients |
URI | https://link.springer.com/article/10.1007/s10067-019-04438-z https://www.ncbi.nlm.nih.gov/pubmed/30810912 https://www.proquest.com/docview/2186632252 https://www.proquest.com/docview/2186623981 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1da9sw8OgHjL2MtftK1wYN9rYFGkWS7cckJC0tDWVdIH0y-qSBzh5x8tJf3ztHTlu6FfoksE6yudOd7nxfAN-dyXoqBNWxNsiOsFYhS6VouB4n3mmnEh_qANmJOp2Ks5mcxaSwqol2b1yStaR-lOyGkhVNX_qZL5BN77ZhV5Ltjqd4yvsb-ctjn7wkIQmTpTFV5t97PL2OnumYz_yj9bUzfg_vor7I-msC78GWL_bhzUX0iH-A62nlw-qWBBYrA1vc-BXqoOXcsXUnHaYrpgs2pzSQRs7hA8coMKsoqUoz-0MhOgs2L9jl1RWLlVarjzAdj34PTzuxXULHim62RBxrxxHZgWrsGTQDQhDK6GBSF5yQMthjbmQmJE8yRAsP1ihjtbFktKVc9z7BTlEW_gsw6aTyPR2cMkbYVKQu487ptBukQYNEt6DbYC23sZY4tbS4zR-qIBOmc8R0XmM6v2vBj82av-tKGi9CHzbEyCNXVTn1z1IkgXgLvm2mkR_IyaELX64iDBU17Lbg85qIm9f1UP9B_QhX_2yo-rD5_7_l4HXgX-Etr08YRUUews5ysfJHqLksTRu2k1nSht3-eDCY0HhyfT7CcTCaXP7C2aEatuvDfA9neuvj |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFRSCbhU5R0osEhwAotmvV7bB4R4tEppG1W0kdqT2aeIVOw2ToToR_UbmbHXiVBFb73au-vRvHbG8wJ4bXUeS-9lZIxPImGMRJHK0HHdTJ1VVqbONwmyIzkci2_HyfEKXHa1MJRW2enERlHbytA_8vc0O0kS9_GPZ-cRTY2i6Go3QqNli1335ze6bPWHna9I3zecb28dfRlGYapAZMQgnyEoynKEyVMrOo3WsvdCauV1Zr0VSeLNJtdJLhKe5uiRc2-01EZpQ75NxlWM596CVRGjK9OD1c9bo4PvC93Pw4y-NCXtlmehTCcU6-HNgK47BSMEqpmLf6_CK_btldhsc-Vtr8NasFXZp5a57sGKK-_D7f0QjX8AJ-Pa-fkpKUtWeTb96eZo_1YTy9opPkzVTJVsQiUonY7FB5ZRUlhZUYdo9ovSg6ZsUrKDw0MWurzWD2F8I0h9BL2yKt0TYIlNpIuVt1JrYTKR2Zxbq7KBTzQ6Q6oPgw5rhQl9zGmcxmmx7MBMmC4Q00WD6eKiD28Xe87aLh7Xrt7oiFEEia6LJf_14dXiNcoiBVhU6ap5WEMNFQd9eNwScfG5GG0vtM1w97uOqsvD_w_L0-theQl3hkf7e8Xezmj3GdzlDXdRNuYG9GbTuXuOFtNMvwhsyuDHTUvGX9YPJzg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcKgVii_id0-rrqBPGtpsdjfJg4hYj9ZqKdSD8ynuJx5oUi93iP1p_jpnks0dUuxbX5PdzTBfO5P5AnjuTJmpEFRibZCJsFahSBXouO7l3mmnch-6BNljdTARH6ZyugF_hloYSqscdGKnqF1j6R_5Ls1OUsR9fDfEtIiT_fGbs58JTZCiSOswTqNnkSP_-xe6b-3rw32k9QvOx-8_vztI4oSBxIq0XCBY2nGEL1BbOoOWcwhCGR1M4YITUga7x40sheR5id45D9YoY7Wx5OcUXGd47jW4nmcyJRnLpytnjwJ43bS-PCc9VxaxYCeW7eEdgU48hSUEKpzzfy_FC5buhShtd_mNb8HNaLWytz2b3YYNX9-BrU8xLn8Xvkxaj_gitcmawObf_BIt4WbmWD_Ph-mW6ZrNqBhl0Lb4wDFKD6sb6hXNflCi0JzNanZyespiv9f2HkyuBKX3YbNuar8NTDqpfKaDU8YIW4jCldw5XaRBGnSL9AjSAWuVjR3NabDG92rdi5kwXSGmqw7T1fkIXq72nPX9PC5dvTMQo4qy3VZrThzBs9VrlEoKtejaN8u4hlorpiN40BNx9bkMrTC00nD3q4Gq68P_D8vDy2F5ClsoD9XHw-OjR3CDd8xFaZk7sLmYL_1jNJ0W5knHowy-XrVQ_AV30ioI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+rheumatoid+factor+as+an+immunological+and+prognostic+marker+in+PSS+patients&rft.jtitle=Clinical+rheumatology&rft.au=Ma%C5%9Bli%C5%84ska%2C+Maria&rft.au=Ma%C5%84czak%2C+Ma%C5%82gorzata&rft.au=Kwiatkowska%2C+Brygida&rft.date=2019-05-01&rft.eissn=1434-9949&rft.volume=38&rft.issue=5&rft.spage=1301&rft_id=info:doi/10.1007%2Fs10067-019-04438-z&rft_id=info%3Apmid%2F30810912&rft.externalDocID=30810912 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0770-3198&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0770-3198&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0770-3198&client=summon |